These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4588717)
41. [Biochemical principles of the development of new cardiac drugs of the digitalis type]. Repke KR Pharmazie; 1972 Nov; 27(11):693-701. PubMed ID: 4265944 [No Abstract] [Full Text] [Related]
42. Digoxin and digitoxin in man: influence on rubidium transport in red blood cells in vitro. Cohen HC Acta Cardiol; 1971; 26(5):443-57. PubMed ID: 5316232 [No Abstract] [Full Text] [Related]
43. [Recent advances in digitalis therapy]. Kolenda KD; Grille W; Kokenge F Z Arztl Fortbild (Jena); 1982 Nov; 76(21):923-30. PubMed ID: 7170801 [No Abstract] [Full Text] [Related]
44. [Absorption of digitalis glycosides]. Gillmann H Dtsch Med Wochenschr; 1971 Jul; 96(27):1175. PubMed ID: 5088873 [No Abstract] [Full Text] [Related]
45. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. Caldwell JH; Bush CA; Greenberger NJ J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315 [TBL] [Abstract][Full Text] [Related]
46. Studies on digitalis. VII. Influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites. Storstein L Clin Pharmacol Ther; 1976 Aug; 20(2):158-66. PubMed ID: 947651 [TBL] [Abstract][Full Text] [Related]
47. Absorption of digoxin from different oral preparations in normal subjects during steady state. Huffman DH; Manion CV; Azarnoff DL Clin Pharmacol Ther; 1974 Aug; 16(2):310-7. PubMed ID: 4850376 [No Abstract] [Full Text] [Related]
48. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin. Härtel G; Manninen V; Melin J; Apajalahti A Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756 [No Abstract] [Full Text] [Related]
49. [Pharmakokinetics of digoxin and digitoxin]. Baczyński R Pol Tyg Lek; 1977 May; 32(20):773-6. PubMed ID: 866273 [No Abstract] [Full Text] [Related]
50. An improved method for replacing one digitalis glycoside with another. Jelliffe RW Med Times; 1970 Jan; 98(1):105-17. PubMed ID: 5411844 [No Abstract] [Full Text] [Related]
51. [Which digitalis therapy is still justified today? (author's transl)]. Kümmell HC MMW Munch Med Wochenschr; 1980 May; 122(21):787-91. PubMed ID: 6771597 [TBL] [Abstract][Full Text] [Related]
57. Proceedings: Digoxin dosage in patients with impaired kidney function. Dettli L; Ohnhaus EE; Spring P Br J Pharmacol; 1972 Feb; 44(2):373P. PubMed ID: 4668631 [No Abstract] [Full Text] [Related]
58. Simultaneous analysis of digitoxin and its clinically relevant metabolites using high-performance liquid chromatography and radioimmunoassay. Santos SR; Kirch W; Ohnhaus EE J Chromatogr; 1987 Aug; 419():155-64. PubMed ID: 3667774 [TBL] [Abstract][Full Text] [Related]
59. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy. Wagner JG Am Heart J; 1974 Aug; 88(2):133-8. PubMed ID: 4601506 [No Abstract] [Full Text] [Related]
60. Application of canine plasma kinetics of digoxin and digitoxin to therapeutic digitalization in the dog. Breznock EM Am J Vet Res; 1973 Aug; 34(8):993-9. PubMed ID: 4755779 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]